# AIDS Malignancy Consortium

Source: https://onco.cc/companies/aids-malignancy-consortium/  
OnCo record `aids-malignancy-consortium` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The AIDS Malignancy Consortium is the US National Cancer Institute-supported trials group for cancers in people with HIV, founded in 1995 with 38 sites worldwide; in OnCo it leads ANCHOR, the trial showing that treating anal precancer prevents anal cancer.

## Summary

The AIDS Malignancy Consortium (AMC), now styled the Consortium for Advancing Management and Prevention of Cancer in People with HIV, is a National Cancer Institute-supported clinical trials group founded in 1995 to support innovative trials for HIV-related cancers; it is composed of 38 clinical trials sites worldwide, five working groups, an administrative office, a statistical office and an operations and data management office (amcoperations.com). Its website states no postal address, so no seat is given here. ClinicalTrials.gov names it lead sponsor (NETWORK class, with the National Cancer Institute, the Emmes Company and the universities of Arkansas, California San Francisco and Arizona as collaborators) of ANCHOR (NCT02135419, phase 3, treatment against active monitoring of anal high-grade squamous intraepithelial lesions in people with HIV), the trial recorded in OnCo. It has no products of its own.

## Fields

- Kind: Company
- Last checked: 2026-09-25
- Also known as: AMC; Consortium for Advancing Management and Prevention of Cancer in People with HIV
- Tags: ctgov-sponsor; cooperative-group
- HQ: United States (seat not stated)
- Type: cooperative-group
- Website: https://amcoperations.com

## Sources

- Official website: https://amcoperations.com
- ClinicalTrials.gov: trials led by AIDS Malignancy Consortium: https://clinicaltrials.gov/search?lead=AIDS%20Malignancy%20Consortium

## Connected records

- cancers: [Anal cancer (squamous cell carcinoma)](https://onco.cc/cancers/anal/), [Anal high-grade squamous intraepithelial lesions (precursor)](https://onco.cc/cancers/anal-hsil-precursor/)
- trials: [ANCHOR](https://onco.cc/trials/anchor/)

---
JSON: https://onco.cc/api/v1/entities/aids-malignancy-consortium.json